Terms: = Leukemia AND CSF3R, CD114, 1441, ENSG00000119535, GCSFR AND Prognosis
45 results:
1. A Case of Chronic Eosinophilic leukemia with csf3r-Mutant Clone and Transformed to Secondary Acute Myeloid leukemia.
Wu Y; Yang X
Clin Lab; 2024 Apr; 70(4):. PubMed ID: 38623671
[TBL] [Abstract] [Full Text] [Related]
2. [Granulocyte-colony stimulating factor-producing multiple myeloma presenting with neutrophilia].
Yokoi M; Kondo T; Shimizu R; Uchida K; Hayashi S; Nishimura H; Kondo E; Wada H
Rinsho Ketsueki; 2023; 64(8):735-740. PubMed ID: 37673624
[TBL] [Abstract] [Full Text] [Related]
3. csf3r-mutant chronic myelomonocytic leukemia is a distinct clinically subset with abysmal prognosis: a case report and systematic review of the literature.
Guastafierro V; Ubezio M; Manes N; Milanesi C; Della Porta M; Bonometti A
Leuk Lymphoma; 2023 Sep; 64(9):1566-1573. PubMed ID: 37395413
[TBL] [Abstract] [Full Text] [Related]
4. [Impact of
Li RQ; Wen XL; Zhang XL; Dong CX; Wang MF; Liu XX; Huang YJ; Tan YH; Chang JM; Zhang RJ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Jun; 31(3):628-632. PubMed ID: 37356918
[TBL] [Abstract] [Full Text] [Related]
5. Integrated transcriptome, proteome and single-cell sequencing uncover the prognostic and immunological features of colony-stimulating factor 3 receptor in pan-cancer.
Song L; Jiang F; Tian Y; Cao X; Zhu M; Zhang J; Wang X; Deng L
J Gene Med; 2023 Oct; 25(10):e3508. PubMed ID: 36998239
[TBL] [Abstract] [Full Text] [Related]
6. [Restratifying the prognosis of acute myeloid leukemia patients with CEBPA double mutations based on csf3r mutations and measurable residual disease].
Su L; Tan YH; Lin H; Han W; Yang YP; Liu XL; Sun JN; Liu QJ; Gao SJ
Zhonghua Xue Ye Xue Za Zhi; 2022 Dec; 43(12):1021-1027. PubMed ID: 36709108
[No Abstract] [Full Text] [Related]
7. Frequency and clinical impact of WT1 mutations in the context of CEBPA-mutated acute myeloid leukemia.
Wang T; Hua H; Wang Z; Wang B; Cao L; Qin W; Wu P; Cai X; Chao H; Lu X
Hematology; 2022 Dec; 27(1):994-1002. PubMed ID: 36066283
[TBL] [Abstract] [Full Text] [Related]
8. Distinct genomic landscape of Chinese pediatric acute myeloid leukemia impacts clinical risk classification.
Liu T; Rao J; Hu W; Cui B; Cai J; Liu Y; Sun H; Chen X; Tang Y; Chen J; Wang X; Wang H; Qian W; Mao B; Guo S; Wang R; Liu Y; Shen S
Nat Commun; 2022 Mar; 13(1):1640. PubMed ID: 35347147
[TBL] [Abstract] [Full Text] [Related]
9. The prognostic factors in acute myeloid leukaemia with double-mutated CCAAT/enhancer-binding protein alpha (CEBPAdm).
Wei H; Zhou C; Liu B; Lin D; Li Y; Wei S; Gong B; Zhang G; Liu K; Gong X; Fang Q; Liu Y; Qiu S; Gu R; Song Z; Chen J; Yang M; Zhang J; Jin J; Wang Y; Mi Y; Wang J
Br J Haematol; 2022 May; 197(4):442-451. PubMed ID: 35274287
[TBL] [Abstract] [Full Text] [Related]
10. Chronic neutrophilic leukemia: 2022 update on diagnosis, genomic landscape, prognosis, and management.
Szuber N; Elliott M; Tefferi A
Am J Hematol; 2022 Apr; 97(4):491-505. PubMed ID: 35089603
[TBL] [Abstract] [Full Text] [Related]
11. The clinical characteristics and prognosis of Chinese acute myeloid leukemia patients with csf3r mutations.
Chen X; Xu J; Fang F; Xu Z; Tan Y; Chang J; Muyey DM; Wang H
Int J Lab Hematol; 2022 Apr; 44(2):364-370. PubMed ID: 34818692
[TBL] [Abstract] [Full Text] [Related]
12. Laboratory evaluation and prognostication among adults and children with CEBPA-mutant acute myeloid leukemia.
Mendoza H; Podoltsev NA; Siddon AJ
Int J Lab Hematol; 2021 Jul; 43 Suppl 1():86-95. PubMed ID: 34288448
[TBL] [Abstract] [Full Text] [Related]
13. CEBPA-bZip mutations are associated with favorable prognosis in de novo AML: a report from the Children's Oncology Group.
Tarlock K; Lamble AJ; Wang YC; Gerbing RB; Ries RE; Loken MR; Brodersen LE; Pardo L; Leonti A; Smith JL; Hylkema TA; Woods WG; Cooper TM; Kolb EA; Gamis AS; Aplenc R; Alonzo TA; Meshinchi S
Blood; 2021 Sep; 138(13):1137-1147. PubMed ID: 33951732
[TBL] [Abstract] [Full Text] [Related]
14. csf3r T618I, SETBP1 G870S, SRSF2 P95H, and ASXL1 Q780* tetramutation co-contribute to myeloblast transformation in a chronic neutrophilic leukemia.
Qian Y; Chen Y; Li X
Ann Hematol; 2021 Jun; 100(6):1459-1461. PubMed ID: 33822276
[TBL] [Abstract] [Full Text] [Related]
15. Combined inhibition of JAK/STAT pathway and lysine-specific demethylase 1 as a therapeutic strategy in csf3r/CEBPA mutant acute myeloid leukemia.
Braun TP; Coblentz C; Curtiss BM; Coleman DJ; Schonrock Z; Carratt SA; Callahan RL; Maniaci B; Druker BJ; Maxson JE
Proc Natl Acad Sci U S A; 2020 Jun; 117(24):13670-13679. PubMed ID: 32471953
[TBL] [Abstract] [Full Text] [Related]
16. Mutation topography and risk stratification for de novo acute myeloid leukaemia with normal cytogenetics and no nucleophosmin 1 (NPM1) mutation or Fms-like tyrosine kinase 3 internal tandem duplication (FLT3-ITD).
Zhou YL; Wu LX; Peter Gale R; Wang ZL; Li JL; Jiang H; Jiang Q; Jiang B; Cao SB; Lou F; Sun Y; Wang CC; Liu YR; Wang Y; Chang YJ; Xu LP; Zhang XH; Liu KY; Ruan GR; Huang XJ
Br J Haematol; 2020 Jul; 190(2):274-283. PubMed ID: 32103499
[TBL] [Abstract] [Full Text] [Related]
17. [Analysis of Clinical Features and prognosis of Patients with Chronic Neutrophil leukemia].
Guo YJ; Wang Y; Wang LH; Zuo YB; Niu ZY; Lin FR; Zhang JY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Feb; 28(1):82-87. PubMed ID: 32027257
[TBL] [Abstract] [Full Text] [Related]
18. Chronic neutrophilic leukemia: 2020 update on diagnosis, molecular genetics, prognosis, and management.
Szuber N; Elliott M; Tefferi A
Am J Hematol; 2020 Feb; 95(2):212-224. PubMed ID: 31769070
[TBL] [Abstract] [Full Text] [Related]
19. Next-generation sequencing reveals unique combination of mutations in cis of csf3r in atypical chronic myeloid leukemia.
Yun JW; Yoon J; Jung CW; Lee KO; Kim JW; Kim SH; Kim HJ
J Clin Lab Anal; 2020 Feb; 34(2):e23064. PubMed ID: 31692115
[TBL] [Abstract] [Full Text] [Related]
20. Companion gene mutations and their clinical significance in AML with double mutant CEBPA.
Zhang Y; Wang F; Chen X; Zhang Y; Wang M; Liu H; Teng W; Cao P; Nie D; Ma X; Wang T; Lu P; Liu H
Cancer Gene Ther; 2020 Aug; 27(7-8):599-606. PubMed ID: 31477806
[TBL] [Abstract] [Full Text] [Related]
[Next]